Scott N. Boyle

Companies

• C4 Therapeutics (United States)Chief Business Officer Mar 17, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• C4 Therapeutics (United States) CCCC298,801 shares²$862.0K at $2.88Feb 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 14, 2026Shares withheld for tax 7,269 shares at $1.89 of C4 Therapeutics (United States)²
• Feb 14, 2026Exercised options 20,950 shares of C4 Therapeutics (United States)²
• Feb 13, 2026Shares withheld for tax 1,735 shares at $1.89 of C4 Therapeutics (United States)²
• Feb 13, 2026Exercised options 5,000 shares of C4 Therapeutics (United States)²
• Feb 13, 2026Granted 200,000 shares of C4 Therapeutics (United States)²
• Feb 18, 2025Sold 669 shares at $3.15 of C4 Therapeutics (United States)³
• Feb 14, 2025Shares withheld for tax 2,368 shares at $3.18 of C4 Therapeutics (United States)³
• Feb 14, 2025Sold 490 shares at $3.15 of C4 Therapeutics (United States)³
• Feb 14, 2025Granted 56,500 shares of C4 Therapeutics (United States)³
• Feb 13, 2025Shares withheld for tax 1,735 shares at $3.20 of C4 Therapeutics (United States)³
• Nov 7, 2024Shares withheld for tax 1,102 shares at $6.04 of C4 Therapeutics (United States)⁴
• Nov 7, 2024Exercised options 3,750 shares of C4 Therapeutics (United States)⁴
• Sep 16, 2024Shares withheld for tax 661 shares at $6.36 of C4 Therapeutics (United States)⁵
• Sep 16, 2024Exercised options 2,250 shares of C4 Therapeutics (United States)⁵
• Feb 14, 2024Granted 27,300 shares of C4 Therapeutics (United States)⁶
• Feb 13, 2024Shares withheld for tax 1,735 shares at $6.53 of C4 Therapeutics (United States)⁶
• Aug 30, 2023Shares withheld for tax 661 shares at $2.93 of C4 Therapeutics (United States)⁷
• Aug 30, 2023Exercised options 2,250 shares of C4 Therapeutics (United States)⁷
• Feb 13, 2023Granted 20,000 shares of C4 Therapeutics (United States)⁸
• Jan 30, 2023Shares withheld for tax 1,222 shares at $7.78 of C4 Therapeutics (United States)⁹
• Jan 30, 2023Exercised options 3,750 shares of C4 Therapeutics (United States)⁹
• May 26, 2022Shares withheld for tax 1,102 shares at $7.01 of C4 Therapeutics (United States)¹⁰
• May 25, 2022Exercised options 3,750 shares of C4 Therapeutics (United States)¹¹